•  
  •  
  •  
  •  

2025-12-11 22:28:01

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Oswal Pumps Ltd receives LoA from MSEDCL for Rs. 380 crores
  • GEM Aromatics begins Commercial Production of Cooling Agents & Clove Products at Dahej Facility
  • Cyient Strengthens Middle East Operations, announces Strategic Acquisition of Abu Dhabi-based Technology Consulting and Digital Services Company
  • Astra Microwave Products Ltd receives order worth Rs. 171.38 crores
  • Infibeam Avenues Ltd to be rebranded as 'AvenuesAI Ltd'

Keywords Selected:  Pharmaceuticals

Research

  • Kotak Institutional Equities - Pharmaceuticals: IPM pulse - gaining momentum
  • Company Update - P&G Health - ICICI Direct
  • Quant Pick - Cadila Healthcare - ICICI Direct
  • Q2FY22 Result Update - Syngene International - ICICI Direct
  • Syngene International Ltd - Lack of near term triggers - YES Securities
  • Syngene International Ltd - Lower gross margin lead to EBIDTA miss - YES Securities

IPO News

  • Accretion Pharmaceuticals' IPO Opens for subscription today, Price Band set at ₹96-101 per Share
  • Accretion Pharmaceuticals Ltd IPO to open for subscription on May 14, 2025
  • Senores Pharmaceuticals IPO subscribed 13.93 times on Day 2
  • Senores Pharmaceuticals IPO fully subscribed on Day 1
  • Senores Pharmaceuticals gets Sebi nod for IPO

Stock Report

  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Loteprednol Etabonate and Tobramycin Ophthalmic Suspension, 0.5%/0.3%
  • Suven Life Sciences achieved 100% Patient Enrolment Milestone in Phase-2b Clinical Trial of Ropanicant for Major Depressive Disorder
  • Glenmark Pharmaceuticals Inc., USA to launch Leucovorin Calcium for Injection USP, 350 mg/vial Single-Dose Vial
  • Cipla launches Yurpeak® (tirzepatide) for the treatment of Obesity and Type 2 Diabetes
  • Fermenta Board approves INR 110 Crore Capex at Dahej for Plant-based Vitamin D3, Green Chemistry Enzyme, and Vitamin D3 Derivatives
  • GMP Inspection by Malta Medicines Authority at Alkem's manufacturing facility located at Daman, India
  • Zydus launches biosimilar Denosumab 120 mg SC - protecting bone health in cancer patients
  • Zydus and Formycon enter into an Exclusive Partnership for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab), in US and Canada
  • Caplin Steriles gets USFDA approval for Linezolid Injection, Infusion bags
  • Caplin Steriles granted final approval by USFDA for Acetaminophen Injection, infusion bags
  • Venus Remedies Marks Completion of AMR Licensing Milestones with Final Rs. 11 Crore Payment
  • EDQM issues CEP Certificate for MINOXIDIL to IOL Chemicals & Pharmaceuticals Ltd
  • Senores Pharmaceuticals receives Philippine FDA approval for 10 products
  • Anuh Pharma Ltd granted CEP from EDQM for Sulfadimethoxine
  • Lupin receives tentative approval from U.S. FDA for Siponimod Tablets
  • Lupin and Valorum Enter into an Exclusive Licensing Agreement for Biosimilar Armlupeg™ in the United States
  • Zydus receives EIR for the injectable facility located at Jarod
  • Granules India's Packaging Facility in US Completes FDA inspection with Zero Observations
  • ZIM Laboratories Ltd receives approval from CDSCO - Directorate General of Health Services for Naproxen + Esomeprazole Capsules
  • SPARC announces the U.S. District Court Grants Summary Judgement in Favour of SPARC for Sezaby PRV
  • Appointment of Daniel J. O'Connor as CEO of Jubilant Therapeutics Inc.
  • Granules India Strengthens R&D Leadership with Two New Centres of Excellence at IIT Hyderabad's Technology Research Park
  • US FDA Accepts Wockhardt's New Drug Application for Breakthrough Antibiotic Zaynich
  • Venus Remedies Ltd update on resolution Of Income Tax matters and Elimination of Contingent Liability

Industry News

  • NYSE Listed Amneal Pharmaceuticals begins Commercial Operations in India

Latest Post

  • Oswal Pumps Ltd receives LoA from MSEDCL for Rs. 380 crores
  • GEM Aromatics begins Commercial Production of Cooling Agents & Clove Products at Dahej Facility
  • Cyient Strengthens Middle East Operations, announces Strategic Acquisition of Abu Dhabi-based Technology Consulting and Digital Services Company
  • Astra Microwave Products Ltd receives order worth Rs. 171.38 crores
  • Infibeam Avenues Ltd to be rebranded as 'AvenuesAI Ltd'


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024